TickerFacts.

Labcorp Holdings Inc. (LH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.07B
Year ended 2025-12-31
$2.19B
Trailing 12 months to 2026-06-30
+1.5%
3-year compound annual growth
$3.63B2007-12-31: $939.80M2008-12-31: $1.02B2009-12-31: $1.13B2010-12-31: $1.18B2011-12-31: $1.18B2012-12-31: $1.25B2013-12-31: $1.22B2014-12-31: $1.16B2015-12-31: $1.45B2016-12-31: $1.77B2017-12-31: $1.84B2018-12-31: $1.88B2019-12-31: $1.91B2020-12-31: $3.07B2021-12-31: $3.63B2022-12-31: $1.97B2023-12-31: $1.30B2024-12-31: $1.73B2025-12-31: $2.07B$2.07B
2007-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$2.07B+19.4%2026-02-24, From 2025-01-01
2024-12-31$1.73B+32.8%2026-02-24, From 2024-01-01
2023-12-31$1.30B-34.0%2026-02-24, From 2023-01-01
2022-12-31$1.97B-45.6%2025-02-25, From 2022-01-01
2021-12-31$3.63Bn/c2024-02-26, From 2021-01-01
2020-12-31$3.07B+61.0%2023-02-28, From 2020-01-01
2019-12-31$1.91B+1.6%2022-02-25, From 2019-01-01
2018-12-31$1.88B+2.1%2021-02-25, From 2018-01-01
2017-12-31$1.84B+3.9%2020-02-28, From 2017-01-01
2016-12-31$1.77Bn/c2019-02-28, From 2016-01-01
2015-12-31$1.45B+25.8%2018-02-27, From 2015-01-01
2014-12-31$1.16B-5.3%2016-03-01, From 2014-01-01
2013-12-31$1.22B-2.6%2016-03-01, From 2013-01-01
2012-12-31$1.25B+6.2%2015-02-26, From 2012-01-01
2011-12-31$1.18B-0.2%2014-02-25, From 2011-01-01
2010-12-31$1.18B+4.5%2013-02-26, From 2010-01-01
2009-12-31$1.13B+10.6%2012-02-24, From 2009-01-01
2008-12-31$1.02B+8.8%2011-03-07, From 2008-01-01
2007-12-31$939.80Mn/a2010-02-24, From 2007-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Labcorp Holdings Inc. (LH)2025-12-31$2.07B+19.4%
Quest Diagnostics Inc (DGX)2025-12-31$2.13B+15.6%
Fortrea Holdings Inc. (FTRE)2025-12-31-$794.60Mn/m
Natera, Inc. (NTRA)2025-12-31-$268.15Mn/m
RadNet, Inc. (RDNT)2025-12-31$198.09M-13.8%
Guardant Health, Inc. (GH)2025-12-31-$397.51Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$67.73Mn/m
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m

Compare LH, DGX, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗